Home / Drug shortages / Lisdexamfetamine Dimesylate Capsule

Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Lannett Company, Inc.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Lannett Company, Inc. with status Current. The shortage was first posted on 07/14/2023.

Shortage Details

Status
Current
Company
Lannett Company, Inc.
Package NDC
0527-4665-37
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37)
Initial Posting
07/14/2023
Revised Date

FDA data resources